Similar articles for PMID: 35738903

Year	Number of Results
1995	1
1998	1
2000	2
2001	3
2002	7
2003	3
2004	1
2005	1
2006	2
2007	3
2008	2
2009	2
2010	6
2011	6
2012	5
2013	4
2014	3
2015	5
2016	6
2017	4
2018	5
2019	10
2020	9
2021	13
2022	12
2023	9
2024	0

1

C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma.

Buck AK, Grigoleit GU, Kraus S, Schirbel A, Heinsch M, Dreher N, Higuchi T, Lapa C, Hänscheid H, Samnick S, Einsele H, Serfling SE, Werner RA. Buck AK, et al. J Nucl Med. 2023 Jan;64(1):34-39. doi: 10.2967/jnumed.122.264207. Epub 2022 Jun 23. J Nucl Med. 2023. PMID: 35738903 Free PMC article.

2

Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma.

Lapa C, Hänscheid H, Kircher M, Schirbel A, Wunderlich G, Werner RA, Samnick S, Kotzerke J, Einsele H, Buck AK, Wester HJ, Grigoleit GU. Lapa C, et al. J Nucl Med. 2019 Jan;60(1):60-64. doi: 10.2967/jnumed.118.210997. Epub 2018 May 18. J Nucl Med. 2019. PMID: 29777009 Free article.

3

Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation.

Maurer S, Herhaus P, Lippenmeyer R, Hänscheid H, Kircher M, Schirbel A, Maurer HC, Buck AK, Wester HJ, Einsele H, Grigoleit GU, Keller U, Lapa C. Maurer S, et al. J Nucl Med. 2019 Oct;60(10):1399-1405. doi: 10.2967/jnumed.118.223420. Epub 2019 Mar 8. J Nucl Med. 2019. PMID: 30850502 Free PMC article.

4

CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma.

Lapa C, Herrmann K, Schirbel A, Hänscheid H, Lückerath K, Schottelius M, Kircher M, Werner RA, Schreder M, Samnick S, Kropf S, Knop S, Buck AK, Einsele H, Wester HJ, Kortüm KM. Lapa C, et al. Theranostics. 2017 Apr 8;7(6):1589-1597. doi: 10.7150/thno.19050. eCollection 2017. Theranostics. 2017. PMID: 28529638 Free PMC article.

5

CXCR4-targeted theranostics in oncology.

Buck AK, Serfling SE, Lindner T, Hänscheid H, Schirbel A, Hahner S, Fassnacht M, Einsele H, Werner RA. Buck AK, et al. Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4133-4144. doi: 10.1007/s00259-022-05849-y. Epub 2022 Jun 8. Eur J Nucl Med Mol Imaging. 2022. PMID: 35674738 Free PMC article. Review.

6

Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens.

Bertz H, Illerhaus G, Veelken H, Finke J. Bertz H, et al. Ann Oncol. 2002 Jan;13(1):135-9. doi: 10.1093/annonc/mdf010. Ann Oncol. 2002. PMID: 11863095 Free article. Clinical Trial.

7

[Outcome of haploidentical hematopoietic stem cell transplantation for non-Hodgkin lymphoma].

Xu T, Chen J, Jin ZM, Miao M, Fu CC, Qiu HY, Tang XW, Han Y, Sun AN, Wu DP. Xu T, et al. Zhonghua Xue Ye Xue Za Zhi. 2016 Aug 14;37(8):656-60. doi: 10.3760/cma.j.issn.0253-2727.2016.08.005. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27587245 Free PMC article. Chinese.

8

Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.

Sehgal A, Hoda D, Riedell PA, Ghosh N, Hamadani M, Hildebrandt GC, Godwin JE, Reagan PM, Wagner-Johnston N, Essell J, Nath R, Solomon SR, Champion R, Licitra E, Fanning S, Gupta N, Dubowy R, D'Andrea A, Wang L, Ogasawara K, Thorpe J, Gordon LI. Sehgal A, et al. Lancet Oncol. 2022 Aug;23(8):1066-1077. doi: 10.1016/S1470-2045(22)00339-4. Epub 2022 Jul 12. Lancet Oncol. 2022. PMID: 35839786 Clinical Trial.

9

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial.

Benjamin R, Jain N, Maus MV, Boissel N, Graham C, Jozwik A, Yallop D, Konopleva M, Frigault MJ, Teshima T, Kato K, Boucaud F, Balandraud S, Gianella-Borradori A, Binlich F, Marchiq I, Dupouy S, Almena-Carrasco M, Pannaux M, Fouliard S, Brissot E, Mohty M; CALM Study Group. Benjamin R, et al. Lancet Haematol. 2022 Nov;9(11):e833-e843. doi: 10.1016/S2352-3026(22)00245-9. Epub 2022 Oct 10. Lancet Haematol. 2022. PMID: 36228643 Clinical Trial.

10

Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma.

Gibson JF, Alpdogan O, Subtil A, Girardi M, Wilson LD, Roberts K, Foss F. Gibson JF, et al. J Am Acad Dermatol. 2015 Jun;72(6):1010-5.e5. doi: 10.1016/j.jaad.2015.01.003. J Am Acad Dermatol. 2015. PMID: 25981001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year